I am on Orserdu (elacestrant) for a ESR1 mutation and feeling great but my CA27-29 tumor marker numbers continue to rise. Prior to this medication I was on Capecitabine for a PIC3 mutation and prior to that Piqray. Does any one know what meds work to target both mutations simultaneously?
Mutations: I am on Orserdu (elacestrant... - SHARE Metastatic ...
Mutations
Written by
Healthplus1
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Piqray is a targeted therapy and is given for pic3 mutation. I think you can take Orserdu with targeted therapies. Capecitabine is a chemo drug and is typically given by itself.
There is a new drug Trucap that requires you to have one of three mutations, one of which is pic3. Truqap is a targeted therapy. So you might want to ask your oncologist about that.
Best wishes ,
Helen
Not what you're looking for?
You may also like...
Rising ESR1 Mutations During Aromatase Inhibitor and Palbociclib Therapy
From Oncology October 15, 2022:
Published in The Lancet Oncology 29.09.2022
"This phase...
Overall Survival With Palbociclib and Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer
This "updated exploratory analysis"...
Who has ESR1 how are you doing
I just developed the ESR1 mutation and went on Faslodex and switched to Kisquali. I was wondering...
Pik3 CA mutation
So I recently had a liquid biopsy done because after seven years on Ibrance and letrozole my cancer...
Liquid biopsy approved
Making progress. The biopsy for Pic mutation has been approved. The test will check for 100...